1 Faculty of Health Sciences, Launceston, University of Tasmania, Tasmania, 7249, Australia.
2 Department of Haematology, Specialist Care Australia, Launceston, Tasmania, 7250 Australia.
3 Medical School, University of Saarland, Homburg, Germany.
4 Augusta Medical Centre, Lenah Valley 7008, Tasmania, Australia.
5 Launceston General Hospital, Launceston, Tasmania, 7250 Australia.
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
To study patients receiving anticoagulants with or without antiplatelet
therapy presenting at a regional Australian hospital with bleeding. The
main aims are to explore: (1) patients' characteristics and management
provided; (2) association between the type of anticoagulant and
antiplatelet agent used and the requirement of reversal; (3) and the
length of hospital stay (LoS) in conjunction with bleeding episode and
1. Characteristics of patients receiving anticoagulation therapy who
presented to the LGH-ED with acute bleeding during the study period
between January 2016 and June 2018.
2. Laboratory profile of patients presenting with acute bleeding receiving anticoagulation therapy using lab reference ranges.
|Table 3. Management provided to patients.
|Table 4. Bivariate
association between the anticoagulant therapeutic agent(s) used
before and those recommenced after bleeding event.
|Table 5. Bivariate association between receiving reversal and anticoagulation therapeutic agent(s).
2. Linear regression model for LoS in days